Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 26 Aug 2015
At a glance
- Drugs Opicapone (Primary) ; Repaglinide
- Indications Parkinson's disease; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Bial
- 20 Jun 2012 Primary endpoint amended as reported by ClinicalTrials.gov.
- 29 Feb 2012 New trial record